The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo
Authors:
- 1 March 1992
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neurology
- Vol. 239 (3) , 143-146
Abstract
Peripheral neuropathy is an important and disabling side-effect of cisplatin treatment. A new drug, Org 2766, has been found to prevent this neuropathy up to 1 month after treatment. A group of 18 patients with ovarian cancer, who participated in an earlier randomized study with placebo or Org 2766, together with cisplatin and cyclophophamide, were thereafter prospectively followed up to 2 years after discontinuation of treatment to monitor the development of neurological signs and symptoms and vibration perception threshold (VPT). Exploratory, descriptive data analysis shows that between 1 and 4 months after the last cycle the average sum score for neurological signs and symptoms and VPT had deteriorated compared with 1 month after treatment. Thereafter a gradual but incomplete improvement was seen between 4–12 and 12–24 months after treatment. These changes were seen in all patients regardless of previous treatment with Org 2766 or placebo, but deterioration was less pronounced in patients previously treated with Org 2766. These results suggests that treatment with Org 2766 to prevent a cisplatin-induced neuropathy should possibly be continued up to 4 months after the last cycle of cisplatin.Keywords
This publication has 15 references indexed in Scilit:
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicityJournal of the Neurological Sciences, 1989
- Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in ratsEuropean Journal of Cancer and Clinical Oncology, 1988
- Unusual presentation of cis‐platinum NeuropathyNeurology, 1988
- Electrophysiological study of the peripheral and central neurotoxic effect of cis-platinActa Neurologica Scandinavica, 1987
- High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity.Journal of Clinical Oncology, 1985
- Polyneuropathy Induced by Cisplatin1985
- Peripheral sensory neuropathy and cisplatin chemotherapyNeurology, 1984
- Evidence that the neurotrophic actions of α-MSH may derive from its ability to mimick the actions of a peptide formed in degenerating nerve stumpsJournal of the Neurological Sciences, 1984
- Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation.Journal of Neurology, Neurosurgery & Psychiatry, 1979